Statements (19)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
vaccine
|
| gptkbp:adjuvant |
virosome
|
| gptkbp:alternativeTo |
gptkb:Vaqta
gptkb:Havrix |
| gptkbp:approvedBy |
gptkb:Europe
|
| gptkbp:ATCCode |
gptkb:J07BC02
|
| gptkbp:boosterInterval |
6-12 months after first dose
|
| gptkbp:broadcastOn |
two doses
|
| gptkbp:contains |
inactivated hepatitis A virus
|
| gptkbp:firstDoseAge |
from 1 year
|
| https://www.w3.org/2000/01/rdf-schema#label |
Epaxal
|
| gptkbp:indication |
prevention of hepatitis A
|
| gptkbp:manufacturer |
gptkb:Crucell
|
| gptkbp:routeOfAdministration |
intramuscular injection
|
| gptkbp:status |
prescription only
|
| gptkbp:storage |
2-8°C
|
| gptkbp:usedFor |
gptkb:hepatitis_A
|
| gptkbp:bfsParent |
gptkb:Crucell
|
| gptkbp:bfsLayer |
6
|